{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Central fever",
      "Diclofenac sodium",
      "Ischemic stroke"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31847889",
  "DateCompleted": {
    "Year": "2020",
    "Month": "05",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "05",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "12",
        "Day": "18"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "373",
      "10.1186/s13256-019-2281-7"
    ],
    "Journal": {
      "ISSN": "1752-1947",
      "JournalIssue": {
        "Volume": "13",
        "Issue": "1",
        "PubDate": {
          "Year": "2019",
          "Month": "Dec",
          "Day": "18"
        }
      },
      "Title": "Journal of medical case reports",
      "ISOAbbreviation": "J Med Case Rep"
    },
    "ArticleTitle": "Continuous intravenous low-dose diclofenac sodium to control a central fever after ischemic stroke in the intensive care unit: a case report and review of the literature.",
    "Pagination": {
      "StartPage": "373",
      "MedlinePgn": "373"
    },
    "Abstract": {
      "AbstractText": [
        "Elevation in body temperature within the first 24\u2009hours of ischemic stroke is fairly common and known to be associated with worse outcomes. Only after thoroughly ruling out infection and the noninfectious etiologies and in the appropriate clinical setting should the diagnosis of central fever be made. Acetaminophen and nonsteroidal anti-inflammatory drugs are typical therapeutic options. External cooling is frequently used when pharmacologic interventions are inadequate. However, reports have suggested that neurogenic fevers are somewhat resistant to traditional pharmacologic therapies.",
        "We describe a case of a Caucasian patient with central fever after ischemic stroke not responsive to acetaminophen administration and external cooling. After an initial bolus of diclofenac sodium (0.2\u2009mg/kg in 100\u2009ml of saline solution for 30\u2009minutes), a continuous infusion (75\u2009mg in 50\u2009ml of saline solution) was started. After 5\u2009days of treatment, the patient's body temperature was below 37.5\u2009\u00b0C, and the diclofenac sodium infusion was stopped.",
        "We observed that a low-dose diclofenac sodium infusion was effective in treating fever without systemic side effects. This treatment may be suggested as an alternative to conventional antipyretic drugs, but additional clinical trials are required."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Women, Child, General and Specialistic Surgery, University of Campania \"L. Vanvitelli\", Piazza Miraglia 2, 80138, Naples, Italy."
          }
        ],
        "LastName": "Giaccari",
        "ForeName": "L G",
        "Initials": "LG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Women, Child, General and Specialistic Surgery, University of Campania \"L. Vanvitelli\", Piazza Miraglia 2, 80138, Naples, Italy."
          }
        ],
        "LastName": "Pace",
        "ForeName": "M C",
        "Initials": "MC"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Women, Child, General and Specialistic Surgery, University of Campania \"L. Vanvitelli\", Piazza Miraglia 2, 80138, Naples, Italy."
          }
        ],
        "LastName": "Passavanti",
        "ForeName": "M B",
        "Initials": "MB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Women, Child, General and Specialistic Surgery, University of Campania \"L. Vanvitelli\", Piazza Miraglia 2, 80138, Naples, Italy."
          }
        ],
        "LastName": "Sansone",
        "ForeName": "P",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Women, Child, General and Specialistic Surgery, University of Campania \"L. Vanvitelli\", Piazza Miraglia 2, 80138, Naples, Italy."
          }
        ],
        "LastName": "Esposito",
        "ForeName": "V",
        "Initials": "V"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Women, Child, General and Specialistic Surgery, University of Campania \"L. Vanvitelli\", Piazza Miraglia 2, 80138, Naples, Italy."
          }
        ],
        "LastName": "Aurilio",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [
          "0000-0001-9999-3388"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Women, Child, General and Specialistic Surgery, University of Campania \"L. Vanvitelli\", Piazza Miraglia 2, 80138, Naples, Italy. vincenzo.pota@unicampania.it."
          }
        ],
        "LastName": "Pota",
        "ForeName": "V",
        "Initials": "V"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Med Case Rep",
    "NlmUniqueID": "101293382",
    "ISSNLinking": "1752-1947"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"
    },
    {
      "RegistryNumber": "144O8QL0L1",
      "NameOfSubstance": "Diclofenac"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Brain Ischemia"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Diclofenac"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infusions, Intravenous"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Intensive Care Units"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Stroke"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    }
  ],
  "CoiStatement": "The authors declare that they have no competing interests."
}